Member Info for Kong1

Hi Gibson

I have to agree the management have done a lot of work, deals signed and agreed etc, But some where along the line the fruits of their labour are just not ready for picking. Hence why i say one step forward and two back,
the revenue has to start coming in fast otherwise the dream isnt going to happen.

Gazala69

i`m struggling to understand your thinking, they can only inform the markets when they have news, all news has been posted quickly and informed all, unless you want them to pay for a full spread on the front of the times paper !!

oldertrader its half way down the page and in black

Sheltie
im not sure what you say about the RNS not been anything special and dosent warrant the rise,. AS has just confirmed to the markets that so far everything is going to plan and all tests conducted so far have passed what they wanted to achieve. AS has confirmed what they expected !!!! but it needed to be confirmed which it has !!
Now if you read into the RNS even more it clearly states that AS is already talking to Manufactories and clearly giving orders to start the manufacture of test kits. somewhere along the line, companies are not going to do this without an ORDER or serious confirmation that the product will work as the costs are going to be high.
AS is confident this product is going to work otherwise he wouldnt have put a procurement in place !
surely the RNS is telling us all factually that the product 2 weeks ago was hoping it was going to achieve the results, now its telling us the results are great and they are going to refine to achieve an even greater reliability !!!!!!

The bid price is still going up on the sells, so I’m presuming they are wanting stock to fill a buy

Not sure how much has been covered so far this morning, but Southampton university is testing a company’s saliva test. Along with one or two others and Avactas. I’ve copied the small paragraph from the BBCs story

As well as trialling the Optigene saliva test, the Southampton team are exploring the use of other no-swab saliva-based coronavirus tests with companies including Chronomics, Avacta, MAP Science and Oxford Nanoimaging.

If numbers are on the increase, (virus stats I mean ) The governments can’t afford to close the economy down again.
It’s simply a non starter, so I would think testing will be mandatory virtually everywhere. The virus will be fought differently than Simply being in lock down

I’ve been in opti for about 18 months but seems like it’s one step forward and 2 steps back

I’ve been on one or two shares before that’s Offered so much potential. Always people that’s very educated about the share and always very good info. But alas all don’t end up well. This share looks and seems extremely promising and I do have quite a bit in the share.
Having said that I’m not convinced it will go to £50 but I’m hoping it will.
I’m suspecting from now until then, there will be more deals and more shares to dilute hence why I’m not sure the sp will reach the dizzy heights.
Also we have to be careful that somewhere along the line there might be set backs..
Not keeping an open mind can be dangerous, I’ve seen a few times already

i remember asos going from 7p to 90 in the blink of an eye, then it came down to 50p so i bought £5000 worth then it dropped further to about 30p, I panicked but it slowly edged back up to 50p so I sold straight away, now look at them

Hi Pthc

Not sure Putney lad would want to liase with me considering I was critical of his thoughts, which proved right in the end but I still lost £13k
Not herd of forsure but the last time I logged on was a few months ago and they were going to the city police I think.
At the end of the day, it seems what Koovs did was legal, but whether they mislead any shareholders is something different.
I remember a RNS saying they had 3 months money left in November. I’d made my mind up I was going to sell just before Xmas if no news, but as we all know, Koovs did the dirty only a few weeks after their RNS.
To me that was wrong and I’ve lost my money because they did something different to their RNS, which is misleading to me !!

First time I’ve logged on here for a few months.
Has there been any news as to what is happening if anything ?

Mjw418
You’ve got some serious money in the share then

Wolves
Yep it’s looking that way, ****ed up big style there

Immunodiagnostic Systems Holdings plc.

12 June 2020



Automated assay to detect SARS-CoV-2 antibodies





Immunodiagnostic Systems Holdings plc (IDS), a specialty solution provider to the clinical laboratory diagnostic market, announces a new automated COVID-19 IgG assay (The Test) has achieved CE marking and is expected to be available for sale by the end of this month.

The Test, which arises from the partnership between IDS and Technogenetics, is designed to run on the automated IDS-iSYS analyser. Today IDS and Technogenetics reached a commercial agreement under which IDS shall sell, market and support this Test on a global basis. For territories which do not accept CE marked products, the requisite regulatory approvals will be required.

Test Overview

· Detects specific IgG antibodies indicating past exposure to the COVID-19 virus and immune response;

· Quantitative test determines antibody concentration (titer), not just a 'yes/no' result;

· Highly accurate with a sensitivity of 100%1 and a specificity of 99.4%2, thus meeting the performance criteria specified by MHRA and the Royal College of Pathology, as well as the most common international performance requirements;

· Test results available within 25 minutes.

Unlike many COVID-19 serology assays currently available, this Test is a quantitative assay. It can determine the antibody concentration in patient serum, rather than giving a 'yes/no' result for prior exposure to the virus. Although the clinical level of functional immunity conferred by SARS-CoV-2 IgG antibodies has not yet been determined, we believe quantitative tests may ultimately be valuable in determining immunity status based on the levels of antibody in the blood.

All steps of the Test are automated with no manual reagent preparation required, ensuring minimal hands-on time for lab staff and a high daily throughput.

Well one thing for sure, I’m totally suprised this share hasn’t really moved since what I thought was a great RNS.
Some seriously huge buys recently which bodes well but not sure why the smaller guys haven’t picked up on this yet

Chengdog what the hell are you on about, I’ve merely posted what monetary value other companies are receiving from their test kits.
Timster replied and I said fingers crossed, I suggest you read carefully before wrongly pointing your finger towards others

Fingers crossed timster

Novacyt SA - clinical diagnostics - Says sales of Covid-19 tests totalling EUR135 million at June 1, including EUR45 million already received and forward orders worth an additional EUR90 million. Novacyt says it is selling testing kits to more than 130 countries and wins Zimbabwe contract to supply 1.5 million tests.

Timster
Yes sorry had a blonde moment. I did read the RNS but the dye kicked in ??